Finance

Lists
S1YK34:BVMF
Stryker Corp Bdr
70,91 BRL
0,00%
(0,00) 1D
13-окт., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for S1YK34...
Open
70,63 BRL
High
70,91 BRL
Low
70,63 BRL
Mkt. cap
108,38 млд
Avg. vol.
3,54 миң
Volume
7,00
52-wk high
101,65 BRL
52-wk low
67,62 BRL
Shares outstanding
383,57 млн
No. of employees
56 миң
Open
70,63 BRL
High
70,91 BRL
Low
70,63 BRL
Mkt. cap
108,38 млд
Avg. vol.
3,54 миң
Volume
7,00
52-wk high
101,65 BRL
52-wk low
67,62 BRL
Shares outstanding
383,57 млн
No. of employees
56 миң
News stories
From web sources and news partners
Profile
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States. The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
About Stryker Corp Bdr
CEOKevin A. Lobo
Employees56 миң
Founded1941
HeadquartersКаламазу, Мичиган, Америка Кошмо Штаттары
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
6,06 млд
7,17 млд
6,02 млд
6,59 млд
Cost of goods sold
2,12 млд
2,49 млд
2,19 млд
2,08 млд
Cost of revenue
2,12 млд
2,49 млд
2,19 млд
2,08 млд
Research and development expenses
409,00 млн
388,00 млн
409,00 млн
429,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,99 млд
2,15 млд
2,16 млд
2,13 млд
Operating expense
2,58 млд
2,72 млд
2,75 млд
2,73 млд
Total operating expenses
4,71 млд
5,22 млд
4,95 млд
4,81 млд
Operating income
1,35 млд
1,95 млд
1,07 млд
1,78 млд
Other non operating income
-138,00 млн
420,00 млн
19,00 млн
1,00 млн
EBT including unusual items
1,03 млд
1,70 млд
850,00 млн
1,56 млд
EBT excluding unusual items
1,25 млд
1,81 млд
987,00 млн
1,68 млд
Income tax expense
170,00 млн
856,00 млн
105,00 млн
288,00 млн
Effective tax rate
16,52%
50,21%
12,35%
18,41%
Other operating expenses
-
-
-
-
Net income
859,00 млн
849,00 млн
745,00 млн
1,28 млд
Net profit margin
14,18%
11,84%
12,38%
19,37%
Earnings per share
3,19
4,47
2,60
3,69
Interest and investment income
28,00 млн
31,00 млн
34,00 млн
26,00 млн
Interest expense
-
-607,00 млн
-148,00 млн
-141,00 млн
Net interest expenses
28,00 млн
-576,00 млн
-114,00 млн
-115,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,66 млд
2,27 млд
1,37 млд
2,08 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору